Renal manifestations of hepatitis C infection

被引:88
作者
Daghestani, L
Pomeroy, C
机构
[1] Univ Kentucky, Div Infect Dis, Med Ctr, Dept Med, Lexington, KY 40501 USA
[2] Univ Kentucky, Dept Vet Affairs, Med Ctr, Lexington, KY 40501 USA
关键词
D O I
10.1016/S0002-9343(99)00014-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis C is an important cause of renal disease, and renal complications may be the presenting manifestation of hepatitis C infection. About half of patients present with evidence of renal insufficiency, and up to one quarter present with nephrotic syndrome. Others present with proteinuria or evidence of diminished renal function. The pathogenesis of hepatitis C-associated renal disease remains incompletely defined, but most evidence suggests that glomerular injury results from deposition of circulating immune complexes in the subendothelium and mesangium. Membranoproliferative glomerulonephritis, with or without cryoglobulinemia, is the most common renal lesion. Interferon alpha-2b is currently the treatment of choice. However, success is limited, with many patients failing to respond or suffering relapse upon discontinuation of therapy. Studies of newer treatment modalities, such as longer courses of interferon or the use of ribavirin or immunosuppressive agents, are underway. Hepatitis C-associated renal disease may progress to end-stage renal failure requiring dialysis in about 10% of patients. (C) 1999 by Excerpta Medica, Inc.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 102 条
[1]   Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia [J].
Adinolfi, LE ;
Utili, R ;
Zampino, R ;
Ragone, E ;
Mormone, G ;
Ruggiero, G .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (11) :1067-1072
[2]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[3]  
AGNELLO V, 1995, HOSP PRACT, V30, P29
[4]  
BADER TF, 1997, VIRAL HEPATITIS, P135
[5]   Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C [J].
Bell, H ;
Hellum, K ;
Harthug, S ;
Maeland, A ;
Ritland, S ;
Myrvang, B ;
VonderLippe, B ;
Raknerud, N ;
Skaug, K ;
Gutigard, BG ;
Skjaerven, R ;
Prescott, LE ;
Simmonds, P ;
Bucher, A ;
Lind, E ;
Schulz, T ;
Sundoy, A ;
Barstad, S ;
Storseth, P ;
Nordoy, I ;
Bjark, P ;
Anfinsen, OG ;
Klem, K ;
Stray, N ;
Weberg, R ;
Melsom, M ;
Mosvold, J ;
Haug, J ;
Langtind, J ;
Wetterhus, S ;
Ostborg, J ;
Aadland, E ;
Mowe, M ;
Jahnsen, J ;
Muller, F .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (01) :17-22
[6]   Ribavirin therapy for cryoglobulinemia and thrombocytopenia associated with hepatitis C virus infection [J].
Blanche, P ;
Bouscary, D .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (06) :1472-1473
[7]   Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C [J].
Brunkhorst, R ;
Klein, V ;
Koch, KM .
NEPHRON, 1996, 72 (03) :465-467
[8]  
BURSTEIN DM, 1993, J AM SOC NEPHROL, V4, P1288
[9]   Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection [J].
Casato, M ;
Agnello, V ;
Pucillo, LP ;
Knight, GB ;
Leoni, M ;
DelVecchio, S ;
Mazzilli, C ;
Antonelli, G ;
Bonomo, L .
BLOOD, 1997, 90 (10) :3865-3873
[10]  
CHAUVEAU P, 1993, KIDNEY INT, V43, P5149